Coherus BioSciences, Inc

(NASDAQ:CHRS)

Latest On Coherus BioSciences, Inc (CHRS):

Date/Time Type Description Signal Details
2023-05-31 18:21 ESTNewsCoherus BioSciences falls after regulatory update on cancer drugN/A
2023-05-16 11:48 ESTNewsCoherus BioSciences down 11%, prices $50M offeringN/A
2023-05-15 22:12 ESTNewsCoherus BioSciences plans for $50M stock offering, shares fallN/A
2023-05-10 01:15 ESTNewsCoherus: Biosimilar And Immuno-Oncology Pipeline Setup Could Pay OffN/A
2023-05-08 22:15 ESTNewsCoherus BioSciences Non-GAAP EPS of -$0.75 misses by $0.28, revenue of $32.44M misses by $13.85MN/A
2023-05-08 22:14 ESTNewsCoherus BioSciences, Inc. (CHRS) Q1 2023 Earnings Call TranscriptN/A
2023-05-07 20:25 ESTNewsCoherus BioSciences Q1 2023 Earnings PreviewN/A
2023-05-01 20:30 ESTNewsCoherus spikes as Truist starts at Buy on biosimilar businessN/A
2023-04-28 18:02 ESTNewsCoherus Still Looks Good, Multiple Catalysts This Year (Rating Downgrade)N/A
2023-03-09 14:38 ESTNewsCoherus BioSciences laying off 20% of employeesN/A
2023-03-07 02:43 ESTNewsCoherus BioSciences Non-GAAP EPS of -$0.60 beats by $0.09, revenue of $45.4M misses by $2.57MN/A
2023-03-07 02:43 ESTNewsCoherus BioSciences, Inc. (CHRS) Q4 2022 Earnings Call TranscriptN/A
2023-03-05 21:16 ESTNewsCoherus BioSciences Q4 2022 Earnings PreviewN/A
2023-02-15 22:50 ESTNewsCoherus touts late-stage toripalimab overall survival data in nasopharyngeal carcinomaN/A
2023-01-31 13:52 ESTNewsCoherus BioSciences: Biosimilar Specialist With Approval Shot For Chinese Cancer Drug Looks Like A BuyN/A
2023-01-18 05:59 ESTNewsJunshi's toripalimab meets main goal of late-stage study in lung cancer subtypeN/A
2023-01-09 14:36 ESTNewsCoherus: Launch Of Humira Biosimilar May Boost StockN/A
2023-01-09 14:35 ESTNewsCoherus stock dips amid deal to acquire US rights to Eylea biosimilar FYB203N/A
2022-12-27 20:07 ESTNewsCoherus down 10% on BLA action date delay for toripalimabN/A
2022-12-23 22:23 ESTNewsCoherus sheds 13% on FDA action date for cancer drugN/A
2022-12-17 12:34 ESTNewsStocks To Watch: Earnings For Micron, Nike And FedEx + Disney Looks For Avatar BlowoutN/A
2022-11-09 03:52 ESTNewsCoherus BioSciences Non-GAAP EPS of -$0.96 misses by $0.32, revenue of $45.42M misses by $10.94MN/A
2022-11-09 03:51 ESTNewsCoherus BioSciences, Inc. (CHRS) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 09:56 ESTNewsCoherus BioSciences Q3 2022 Earnings PreviewN/A
2022-09-19 20:43 ESTNewsCoherus to launch its biosimilar to Roche's eye disorder drug Lucentis in U.S. on Oct. 3N/A
2022-08-24 18:35 ESTNewsCoherus: 2022 Is In Many Ways A Make Or Break YearN/A
2022-08-07 21:42 ESTNewsCoherus BioSciences, Inc.'s (CHRS) CEO Denny Lanfear on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 00:52 ESTNewsCoherus BioSciences GAAP EPS of -$0.65 beats by $0.21, revenue of $60.2M misses by $1.24MN/A
2022-08-03 18:46 ESTNewsCoherus stock soars 14% on FDA nod for Roche Lucentis' interchangeable biosimilar CimerliN/A
2022-08-03 18:45 ESTNewsCoherus BioSciences Q2 2022 Earnings PreviewN/A
2022-07-21 09:36 ESTNewsCoherus/Junshi's toripalimab gets orphan drug tag in EU for head/neck cancer subtypeN/A
2022-07-06 20:18 ESTNewsCoherus, Shanghai Junshi refiling for toripalimab gets FDA review in rare head/neck cancerN/A
2022-05-27 18:07 ESTNewsCoherus: Will Its Chinese Gambit Fail?N/A
2022-05-06 00:48 ESTNewsCoherus BioSciences Non-GAAP EPS of -$1.00 misses by $0.35, revenue of $60.12M misses by $10.42MN/A
2022-05-06 00:47 ESTNewsCoherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q1 2022 Earnings Call TranscriptN/A
2022-05-05 01:14 ESTNewsCoherus BioSciences Q1 consensus EPS, revenue estimates downN/A
2022-05-02 17:59 ESTNewsCoherus, Junshi hit by FDA rejection of cancer therapyN/A
2022-04-14 20:48 ESTNewsCoherus BioSciences SCLC candidate toripalimab granted Orphan Drug statusN/A
2022-03-29 23:30 ESTNewsCoherus gains after issuing long-term guidanceN/A
2022-03-17 04:49 ESTNewsCoherus Biosciences (CHRS) Investor Presentation - slideshowN/A
2022-03-15 19:36 ESTNewsCoherus NSCLC treatment toripalimab meets primary endpoint in late-stage trialN/A
2022-03-15 19:36 ESTNewsCoherus Biosciences appoints chief medical officerN/A
2022-03-07 17:34 ESTNewsJP Morgan downgrades Coherus BioSciences to neutral on toripalimab uncertaintyN/A
2022-03-04 20:34 ESTNewsCoherus esophageal cancer candidate toripalimab succeeds in late-stage trialN/A
2022-02-18 11:03 ESTNewsCoherus BioSciences Non-GAAP EPS of -$0.46 beats by $0.08, revenue of $73.37M misses by $9.24MN/A
2022-02-18 11:03 ESTNewsCoherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-17 13:50 ESTNewsCoherus BioSciences Q4 2021 Earnings PreviewN/A
2022-02-09 09:17 ESTNewsEli Lilly, Innovent draw negative FDA comments for cancer drug ahead of AdCom meetingN/A
2022-02-07 19:37 ESTNewsCoherus slips after JPMorgan cut price target on experimental cancer therapyN/A
2022-01-12 20:14 ESTNewsCoherus BioScience (CHRS) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A

About Coherus BioSciences, Inc (CHRS):

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline includes biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar; and CHS-131, a once-daily oral drug candidate for non-alcoholic steatohepatitis and other metabolic conditions. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.

See Advanced Chart

General

  • Name Coherus BioSciences, Inc
  • Symbol CHRS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 317
  • Fiscal Year EndDecember
  • IPO Date2014-11-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.coherus.com
View More

Valuation

  • Trailing PE 9.32
  • Forward PE 36.76
  • Price/Sales (Trailing 12 Mt.) 2.81
  • Price/Book (Most Recent Quarter) 4.14
  • Enterprise Value Revenue 2.18
  • Enterprise Value EBITDA 6.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.53
  • Next Year EPS Estimate $0.83
  • Next Quarter EPS Estimate $0.25
  • Profit Margin 28%
  • Operating Margin 33%
  • Return on Assets 16%
  • Return on Equity 68%
  • Revenue 475.82 million
  • Earnings Per Share $1.62
  • Revenue Per Share $6.66
  • Gross Profit 295.4 million
  • Quarterly Earnings Growth -10.8%
View More

Highlights

  • Market Capitalization 1.1 billion
  • EBITDA 159.21 million
  • PE Ratio -5.46
  • Analyst Target Price $27.63
  • Book Value Per Share $3.88
View More

Share Statistics

  • Shares Outstanding 72.79 million
  • Shares Float 59.94 million
  • % Held by Insiders 162%
  • % Held by Institutions 125.64%
  • Shares Short 13.42 million
  • Shares Short Prior Month 13.08 million
  • Short Ratio 8.33
  • Short % of Float 23%
  • Short % of Shares Outstanding 18%
View More

Technicals

  • Beta 1.34
  • 52 Week High $22.22
  • 52 Week Low $13.66
  • 50 Day Moving Average 17.12
  • 200 Day Moving Average 17.79
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Coherus BioSciences, Inc (CHRS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Coherus BioSciences, Inc (CHRS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$0.12$0.27-54.97%
2020-09-302020-11-05$N/A$0.33$0.34-2.68%
2020-06-302020-08-06$N/A$0.70$0.29141.13%
2020-03-312020-05-07$116.18 million$0.48$0.481.05%
2019-12-312020-02-27$123.86 million$0.53$0.70-24.18%
2019-09-302019-11-06$111.68 million$0.63$0.4249.43%
2019-06-302019-08-01$83.43 million$0.32-$0.04878.59%
2019-03-312019-05-09$37.1 million-$0.29-$0.4637.2%
2018-12-312019-02-28$N/A-$0.92-$0.84-9.26%
2018-09-302018-11-08$N/A-$0.87-$0.79-10.49%
2018-06-302018-08-08$N/A-$0.68-$0.65-5.17%
2018-03-312018-05-10$N/A-$0.74-$0.70-5.79%
2017-12-312018-03-08$1.56 million-$0.84-$0.80-4.84%
2017-09-302017-11-06$-1395000-$1.09-$0.85-27.63%
2017-06-302017-08-07$1.4 million-$1.08-$1.3922.22%
2017-03-312017-05-08$161000-$1.54-$1.43-8.07%
2016-12-312017-03-13$844000-$1.71-$1.34-27.25%
2016-09-302016-11-09$162.84 million$1.67-$1.57206.16%
2016-06-302016-08-09$14.07 million-$1.72-$1.31-30.85%
2016-03-312016-05-09$12.36 million-$1.67-$1.42-17.61%
2015-12-312016-02-29$10.2 million-$1.35-$1.478.16%
2015-09-302015-11-09$7.17 million-$1.86
2015-06-302015-08-10$6.87 million-$1.56
2015-03-312015-05-11$5.81 million-$1.22
2014-12-312015-03-23$6.49 million-$1.47-$0.64-129.69%
2014-09-302014-12-15$16.05 million-$1.79-$0.86-108.14%

Coherus BioSciences, Inc (CHRS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Coherus BioSciences, Inc (CHRS) Chart:

Coherus BioSciences, Inc (CHRS) News:

Below you will find a list of latest news for Coherus BioSciences, Inc (CHRS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Coherus BioSciences, Inc (CHRS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-180.50CALL0 0778.44TRUE00
2025-07-1810.04CALL0 129146.53FALSE00
2025-07-181.50CALL0 0246.61FALSE00
2025-07-1820CALL0 0584.7FALSE00
2025-07-1830CALL0 0386.63FALSE00
2025-07-1840CALL0 01053.06FALSE00
2025-07-180.50.05PUT0 1190.04FALSE00
2025-07-1810.25PUT0 10483.4TRUE00
2025-07-181.50PUT0 0365.6TRUE00
2025-07-1820PUT0 0247.73TRUE00
2025-07-1830PUT0 0323.34TRUE00
2025-07-1840PUT0 0586.39TRUE00
2025-08-150.50.25CALL0 348328.17TRUE00
2025-08-1510.05CALL0 1039120.72FALSE00
2025-08-151.50.04CALL4 276176.08FALSE0.040
2025-08-1520.05CALL0 63192.29FALSE00
2025-08-1530CALL0 5447.17FALSE00
2025-08-1540CALL0 2658.35FALSE00
2025-08-1550CALL0 1685.34FALSE00
2025-08-150.50.05PUT50 10160.47FALSE0.050
2025-08-1510.3PUT0 72104.18TRUE00
2025-08-151.50PUT0 0380.35TRUE00
2025-08-1520PUT0 2213.88TRUE00
2025-08-1530PUT0 0439.82TRUE00
2025-08-1540PUT0 0306.42TRUE00
2025-08-1550PUT0 0459.86TRUE00
2025-11-210.50.3CALL13 535101.31TRUE0.30
2025-11-2110.12CALL13 293106.86FALSE-0.03-0.2
2025-11-211.50CALL0 0122.43FALSE00
2025-11-2120.05CALL0 36146.94FALSE00
2025-11-2130CALL0 5194.32FALSE00
2025-11-2140CALL0 0214.85FALSE00
2025-11-210.50PUT0 0216.79FALSE00
2025-11-2110PUT0 0176.22TRUE00
2025-11-211.50PUT0 0166.17TRUE00
2025-11-2120PUT0 0222.27TRUE00
2025-11-2130PUT0 0165.66TRUE00
2025-11-2140PUT0 0190.09TRUE00
2026-01-160.50.35CALL0 1242172.83TRUE00
2026-01-1610.25CALL0 2891139.06FALSE00
2026-01-161.50.15CALL0 93103.42FALSE00
2026-01-1620.08CALL40 1131127.03FALSE0.080
2026-01-1630.02CALL0 1533134.77FALSE00
2026-01-1640CALL0 39151.3FALSE00
2026-01-1650CALL0 391163.47FALSE00
2026-01-1670CALL0 28180.93FALSE00
2026-01-16100CALL0 42198.45FALSE00
2026-01-160.50.05PUT0 797.03FALSE00
2026-01-1610PUT0 128127.43TRUE00
2026-01-161.50PUT0 284106.05TRUE00
2026-01-1620PUT0 6192.61TRUE00
2026-01-1630PUT0 2272.37TRUE00
2026-01-1640PUT0 0223.69TRUE00
2026-01-1650PUT0 2338.81TRUE00
2026-01-1670PUT0 0210.07TRUE00
2026-01-16100PUT0 0238.33TRUE00
2026-02-200.50.35CALL0 163212.89TRUE00
2026-02-2010CALL0 0271.81FALSE00
2026-02-201.50CALL0 0299.61FALSE00
2026-02-2020CALL0 0170.85FALSE00
2026-02-2030CALL0 0340.82FALSE00
2026-02-2040CALL0 0234.56FALSE00
2026-02-200.50PUT0 0171.54FALSE00
2026-02-2010PUT0 096.99TRUE00
2026-02-201.50PUT0 085.79TRUE00
2026-02-2020PUT0 0145.88TRUE00
2026-02-2030PUT0 0115.69TRUE00
2026-02-2040PUT0 0209.53TRUE00

Latest CHRS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST90$6.2
Jun 13, 2022 7:59 PM EST79$6.195
Jun 13, 2022 7:59 PM EST100$6.2
Jun 13, 2022 7:59 PM EST80$6.2
Jun 13, 2022 7:59 PM EST20$6.195

Coherus BioSciences, Inc (CHRS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm
2019-10-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1512762/000000000019014253/0000000000-19-014253-index.htm
2019-10-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1512762/000000000019014825/0000000000-19-014825-index.htm
2019-11-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1512762/000000000019015589/0000000000-19-015589-index.htm
2020-01-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000001961720000014/0000019617-20-000014-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000021545719003360/0000215457-19-003360-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000031506619000925/0000315066-19-000925-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000031506620000020/0000315066-20-000020-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000083423720004607/0000834237-20-004607-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000083423720009554/0000834237-20-009554-index.htm
2018-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm
2018-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318020572/0000899243-18-020572-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318022461/0000899243-18-022461-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318024270/0000899243-18-024270-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318025185/0000899243-18-025185-index.htm
2018-11-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318029451/0000899243-18-029451-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924318029452/0000899243-18-029452-index.htm
2019-01-143/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001120/0000899243-19-001120-index.htm
2019-01-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001121/0000899243-19-001121-index.htm
2019-01-153/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001178/0000899243-19-001178-index.htm
2019-01-154/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001180/0000899243-19-001180-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001200/0000899243-19-001200-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001201/0000899243-19-001201-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001203/0000899243-19-001203-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001204/0000899243-19-001204-index.htm
2019-01-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319001717/0000899243-19-001717-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002185/0000899243-19-002185-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002188/0000899243-19-002188-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002189/0000899243-19-002189-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002191/0000899243-19-002191-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002192/0000899243-19-002192-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002193/0000899243-19-002193-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319002197/0000899243-19-002197-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319008784/0000899243-19-008784-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319019764/0000899243-19-019764-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319021944/0000899243-19-021944-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319022200/0000899243-19-022200-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319023816/0000899243-19-023816-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319023989/0000899243-19-023989-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319024242/0000899243-19-024242-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/0000899243-19-025608-index.htm
2019-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319025758/0000899243-19-025758-index.htm
2019-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000089924319025822/0000899243-19-025822-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000090221919000105/0000902219-19-000105-index.htm
2019-11-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000090221919000463/0000902219-19-000463-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000095012320000261/0000950123-20-000261-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000106299320000500/0001062993-20-000500-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000110465920046138/0001104659-20-046138-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000110465920048214/0001104659-20-048214-index.htm
2020-05-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1512762/000110465920059847/0001104659-20-059847-index.htm
2019-12-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1512762/000114036119021718/0001140361-19-021718-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000114420418047629/0001144204-18-047629-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000114420419028264/0001144204-19-028264-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000114420419032103/0001144204-19-032103-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000114420419033657/0001144204-19-033657-index.htm
2018-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518202379/0001193125-18-202379-index.htm
2018-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518219674/0001193125-18-219674-index.htm
2018-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518233150/0001193125-18-233150-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518242736/0001193125-18-242736-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518283952/0001193125-18-283952-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518317130/0001193125-18-317130-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312518322543/0001193125-18-322543-index.htm
2018-11-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312518322615/0001193125-18-322615-index.htm
2019-01-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519007367/0001193125-19-007367-index.htm
2019-02-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519025855/0001193125-19-025855-index.htm
2019-02-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519025857/0001193125-19-025857-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519035894/0001193125-19-035894-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519037999/0001193125-19-037999-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519040451/0001193125-19-040451-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519057442/0001193125-19-057442-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519079560/0001193125-19-079560-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519099216/0001193125-19-099216-index.htm
2019-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519102805/0001193125-19-102805-index.htm
2019-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1512762/000119312519102812/0001193125-19-102812-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519136915/0001193125-19-136915-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519142971/0001193125-19-142971-index.htm
2019-05-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519143027/0001193125-19-143027-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519158318/0001193125-19-158318-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312519190538/0001193125-19-190538-index.htm
2019-10-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1512762/000119312519267059/0001193125-19-267059-index.htm
2019-11-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1512762/000119312519285782/0001193125-19-285782-index.htm
2019-11-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312519288389/0001193125-19-288389-index.htm
2020-01-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312520014265/0001193125-20-014265-index.htm
2020-01-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1512762/000119312520014273/0001193125-20-014273-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000119312520024207/0001193125-20-024207-index.htm
2020-10-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000119312520265594/0001193125-20-265594-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000120919120002581/0001209191-20-002581-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000155837020005682/0001558370-20-005682-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000155837020005749/0001558370-20-005749-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000155837020006962/0001558370-20-006962-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000155837020009645/0001558370-20-009645-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000155837020009657/0001558370-20-009657-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000155837020009669/0001558370-20-009669-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000155837020012841/0001558370-20-012841-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000155837020012864/0001558370-20-012864-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000156459018020492/0001564590-18-020492-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000156459018028562/0001564590-18-028562-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1512762/000156459019005470/0001564590-19-005470-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000156459019018007/0001564590-19-018007-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000156459019027982/0001564590-19-027982-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000156459019028841/0001564590-19-028841-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000156459019041086/0001564590-19-041086-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1512762/000156459019042255/0001564590-19-042255-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1512762/000156459020007383/0001564590-20-007383-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1512762/000156459020007416/0001564590-20-007416-index.htm
2020-04-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1512762/000156459020015549/0001564590-20-015549-index.htm
2020-04-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1512762/000156459020015776/0001564590-20-015776-index.htm
2019-01-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919000859/0001567619-19-000859-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919012553/0001567619-19-012553-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919012731/0001567619-19-012731-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/0001567619-19-021759-index.htm
2019-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919021956/0001567619-19-021956-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919022077/0001567619-19-022077-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919022127/0001567619-19-022127-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919022189/0001567619-19-022189-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/0001567619-19-023319-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/0001567619-20-001038-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001039/0001567619-20-001039-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001040/0001567619-20-001040-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001041/0001567619-20-001041-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001042/0001567619-20-001042-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001043/0001567619-20-001043-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001044/0001567619-20-001044-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001045/0001567619-20-001045-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001046/0001567619-20-001046-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001047/0001567619-20-001047-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001048/0001567619-20-001048-index.htm
2020-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920004636/0001567619-20-004636-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920005741/0001567619-20-005741-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/0001567619-20-010834-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920011016/0001567619-20-011016-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920012456/0001567619-20-012456-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/0001567619-20-012458-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920012977/0001567619-20-012977-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm
2020-08-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920014072/0001567619-20-014072-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920014073/0001567619-20-014073-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920016242/0001567619-20-016242-index.htm
2020-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920017365/0001567619-20-017365-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920017922/0001567619-20-017922-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm
2018-08-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1512762/999999999718007359/9999999997-18-007359-index.htm
2020-05-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1512762/999999999720002749/9999999997-20-002749-index.htm

Coherus BioSciences, Inc (CHRS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Coherus BioSciences, Inc (CHRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 162%
Institutional Ownership: 12564%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-22Mary T SzelaDirectorSell54,997.0017.58966,759.260.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm
2020-06-17Mats WahlstromDirectorSell200,000.0017.153,430,020.000.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012456/0001567619-20-012456-index.htm
2019-10-16Jean-Frederic ViretChief Financial OfficerBuy3,159.0010.0531,747.9510,932.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319025758/0000899243-19-025758-index.htm
2019-06-19Jean-Frederic ViretChief Financial OfficerSell667.0020.0013,340.0011,513.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm
2019-06-19Jean-Frederic ViretChief Financial OfficerSell100.0020.812,081.0011,513.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm
2019-06-19Jean-Frederic ViretChief Financial OfficerSell3,059.0020.3262,166.2211,613.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm
2019-09-18Jean-Frederic ViretChief Financial OfficerBuy3,159.0010.0531,747.9511,672.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319023989/0000899243-19-023989-index.htm
2019-06-18Jean-Frederic ViretChief Financial OfficerSell3,000.0019.3157,926.4012,180.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm
2019-05-30Dennis M LanfearPresident & CEOSell32,398.0019.49631,281.511,284,184.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919012553/0001567619-19-012553-index.htm
2019-03-20Jean-Frederic ViretChief Financial OfficerSell3,000.0014.9244,762.1013,185.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319008784/0000899243-19-008784-index.htm
2019-01-11Dennis M LanfearPresident and CEOBuy50,265.00142,884.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319001204/0000899243-19-001204-index.htm
2019-08-21Jean-Frederic ViretChief Financial OfficerSell260.0020.735,388.6814,571.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm
2019-06-19Jean-Frederic ViretChief Financial OfficerBuy3,159.0010.0531,747.9514,672.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm
2019-08-21Jean-Frederic ViretChief Financial OfficerBuy6,318.0010.0563,495.9014,831.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm
2020-06-22Mary T SzelaDirectorBuy14,997.002.5037,500.0014,997.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm
2020-01-10Dennis M LanfearPresident & CEOBuy59,763.00184,780.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001041/0001567619-20-001041-index.htm
2019-07-15Anicetti Vincent RChief Operating OfficerSell2,500.0019.2048,000.0019,310.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319019764/0000899243-19-019764-index.htm
2019-08-14Anicetti Vincent RChief Operating OfficerSell2,500.0019.0047,500.0019,310.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319021944/0000899243-19-021944-index.htm
2019-09-16Anicetti Vincent RChief Operating OfficerSell2,500.0020.0350,075.0019,310.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319023816/0000899243-19-023816-index.htm
2019-10-14Anicetti Vincent RChief Operating OfficerSell2,500.0018.4046,000.0019,310.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/0000899243-19-025608-index.htm
2019-11-14Anicetti Vincent RChief Operating OfficerSell2,500.0019.2648,150.0019,310.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/0001567619-19-021759-index.htm
2020-07-01Dennis M LanfearPresident & CEOBuy29,994.000.01248.95193,258.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012977/0001567619-20-012977-index.htm
2019-12-16Anicetti Vincent RChief Operating OfficerSell2,500.0018.6946,725.0019,326.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/0001567619-19-023319-index.htm
2019-07-02JAMES HEALYDirectorSell160,000.0022.613,617,600.001,933,221.00https://www.sec.gov/Archives/edgar/data/1512762/000114420419033657/0001144204-19-033657-index.htm
2020-03-03Mats WahlstromDirectorSell4,222.0020.8988,214.89200,000.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920005741/0001567619-20-005741-index.htm
2020-03-03Mats WahlstromDirectorSell113,844.0020.092,287,194.27204,222.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920005741/0001567619-20-005741-index.htm
2019-06-28JAMES HEALYDirectorSell200,000.0022.054,410,000.002,093,221.00https://www.sec.gov/Archives/edgar/data/1512762/000114420419033657/0001144204-19-033657-index.htm
2019-07-15Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2521,810.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319019764/0000899243-19-019764-index.htm
2019-08-14Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2521,810.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319021944/0000899243-19-021944-index.htm
2019-09-16Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2521,810.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319023816/0000899243-19-023816-index.htm
2019-10-14Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2521,810.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/0000899243-19-025608-index.htm
2019-11-14Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2521,810.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/0001567619-19-021759-index.htm
2019-12-16Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2521,826.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/0001567619-19-023319-index.htm
2019-01-11Jean-Frederic ViretChief Financial OfficerBuy16,685.0022,482.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319001203/0000899243-19-001203-index.htm
2020-01-10Jean-Frederic ViretChief Financial OfficerBuy19,365.0022,668.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001039/0001567619-20-001039-index.htm
2019-06-20JAMES HEALYDirectorSell317,130.0021.376,777,068.102,293,221.00https://www.sec.gov/Archives/edgar/data/1512762/000114420419032103/0001144204-19-032103-index.htm
2019-01-11Vladimir VexlerChief Scientific OfficerBuy15,562.0023,390.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319001200/0000899243-19-001200-index.htm
2019-01-11Anicetti Vincent RChief Operating OfficerBuy16,997.0023,699.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319001201/0000899243-19-001201-index.htm
2019-05-22JAMES HEALYDirectorSell257,870.0020.695,335,330.302,610,351.00https://www.sec.gov/Archives/edgar/data/1512762/000114420419028264/0001144204-19-028264-index.htm
2020-01-10Vladimir VexlerChief Scientific OfficerBuy8,900.0028,412.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001040/0001567619-20-001040-index.htm
2018-08-29JAMES HEALYDirectorSell25,000.0020.50512,500.002,868,221.00https://www.sec.gov/Archives/edgar/data/1512762/000114420418047629/0001144204-18-047629-index.htm
2020-01-09JAMES HEALYDirectorBuy29,994.001.6750,000.0030,086.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm
2019-11-18Jean-Frederic ViretChief Financial OfficerSell3,112.0018.8858,757.363,303.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919021956/0001567619-19-021956-index.htm
2019-11-20Jean-Frederic ViretChief Financial OfficerSell3,159.0019.5961,871.863,303.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919022077/0001567619-19-022077-index.htm
2020-06-22Mary T SzelaDirectorBuy20,000.0010.05201,000.0034,997.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm
2018-07-09FINCK BARBARA KChief Medical OfficerSell500.0015.037,515.0037,043.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm
2018-07-10FINCK BARBARA KChief Medical OfficerSell1,260.0015.0018,900.0037,043.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm
2018-08-13FINCK BARBARA KChief Medical OfficerSell1,760.0019.0233,479.9537,043.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318022461/0000899243-18-022461-index.htm
2018-09-10FINCK BARBARA KChief Medical OfficerSell1,760.0018.5832,698.8637,043.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318024270/0000899243-18-024270-index.htm
2018-07-09FINCK BARBARA KChief Medical OfficerBuy500.001.42710.0037,543.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm
2018-07-23Jean-Frederic ViretChief Financial OfficerSell9,291.0018.56172,471.623,779.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318020572/0000899243-18-020572-index.htm
2018-07-10FINCK BARBARA KChief Medical OfficerBuy1,260.001.421,789.2038,303.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm
2018-08-13FINCK BARBARA KChief Medical OfficerBuy1,760.001.422,499.2038,803.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318022461/0000899243-18-022461-index.htm
2018-09-10FINCK BARBARA KChief Medical OfficerBuy1,760.001.422,499.2038,803.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318024270/0000899243-18-024270-index.htm
2020-01-10Anicetti Vincent RChief Operating OfficerBuy19,566.0038,892.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/0001567619-20-001038-index.htm
2020-10-14Jean-Frederic ViretChief Financial OfficerSell6,144.0019.00116,736.0040,423.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920017922/0001567619-20-017922-index.htm
2019-11-21Dennis M LanfearPresident & CEOSell12,500.0018.56231,960.00446,684.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919022189/0001567619-19-022189-index.htm
2018-09-21Jean-Frederic ViretChief Financial OfficerBuy740.0013.509,990.004,519.00https://www.sec.gov/Archives/edgar/data/1512762/000089924318025185/0000899243-18-025185-index.htm
2019-11-20Dennis M LanfearPresident & CEOSell825,000.0018.0014,850,000.00459,184.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919022127/0001567619-19-022127-index.htm
2020-05-20Jean-Frederic ViretChief Financial OfficerSell1,278.0017.6622,569.4846,567.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920011016/0001567619-20-011016-index.htm
2020-01-10Jean-Frederic ViretChief Financial OfficerBuy31,250.0046,841.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001039/0001567619-20-001039-index.htm
2020-01-15Jean-Frederic ViretChief Financial OfficerSell2,798.0020.0856,185.8046,841.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm
2020-02-19Jean-Frederic ViretChief Financial OfficerSell3,159.0022.3370,551.8446,841.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920004636/0001567619-20-004636-index.htm
2020-04-20Anicetti Vincent RChief Operating OfficerSell5,150.0017.0087,550.0047,846.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm
2020-05-18Anicetti Vincent RChief Operating OfficerSell593.0017.1710,181.8148,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/0001567619-20-010834-index.htm
2020-06-17Anicetti Vincent RChief Operating OfficerSell2,500.0017.2243,050.0048,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/0001567619-20-012458-index.htm
2020-07-17Anicetti Vincent RChief Operating OfficerSell15,000.0018.25273,687.0048,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm
2020-08-17Anicetti Vincent RChief Operating OfficerSell5,000.0019.3796,851.0048,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm
2020-09-17Anicetti Vincent RChief Operating OfficerSell5,000.0018.8494,216.0048,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm
2020-10-19Anicetti Vincent RChief Operating OfficerSell3,217.0017.8957,555.6748,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm
2020-01-15Jean-Frederic ViretChief Financial OfficerSell3,520.0019.6769,238.0549,639.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm
2020-02-19Jean-Frederic ViretChief Financial OfficerBuy3,159.0010.0531,747.9550,000.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920004636/0001567619-20-004636-index.htm
2020-01-09JAMES HEALYDirectorBuy20,000.0010.05201,000.0050,086.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm
2020-05-18Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2551,056.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/0001567619-20-010834-index.htm
2020-06-17Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2551,056.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/0001567619-20-012458-index.htm
2020-07-17Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2551,056.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm
2020-08-17Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2551,056.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm
2020-09-17Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2551,056.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm
2020-10-19Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2551,056.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm
2020-10-19Anicetti Vincent RChief Operating OfficerBuy717.0012.709,105.9051,773.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm
2020-02-18Anicetti Vincent RChief Operating OfficerSell5,000.0021.64108,190.0052,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm
2020-04-17Anicetti Vincent RChief Operating OfficerSell5,000.0015.5777,850.0052,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm
2020-01-15Jean-Frederic ViretChief Financial OfficerBuy6,318.0010.0563,495.9053,159.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm
2020-08-17Anicetti Vincent RChief Operating OfficerBuy2,500.0012.7031,750.0053,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm
2020-09-17Anicetti Vincent RChief Operating OfficerBuy2,500.0012.7031,750.0053,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm
2020-06-22Mary T SzelaDirectorBuy20,000.0012.37247,400.0054,997.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm
2020-01-10Vladimir VexlerChief Scientific OfficerBuy31,250.0056,185.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001040/0001567619-20-001040-index.htm
2020-04-17Anicetti Vincent RChief Operating OfficerBuy5,000.002.5012,502.5057,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm
2020-01-17Anicetti Vincent RChief Operating OfficerSell5,000.0019.5697,796.0057,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm
2020-01-17Anicetti Vincent RChief Operating OfficerSell2,500.0019.6949,213.2557,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm
2020-02-18Anicetti Vincent RChief Operating OfficerSell2,500.0021.6454,100.0057,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm
2020-01-17Anicetti Vincent RChief Operating OfficerBuy2,500.0012.7031,750.0060,496.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm
2020-02-18Anicetti Vincent RChief Operating OfficerBuy2,500.0012.7031,750.0060,496.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm
2020-02-18Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2560,496.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm
2020-01-10Anicetti Vincent RChief Operating OfficerBuy31,250.0062,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/0001567619-20-001038-index.htm
2020-01-17Anicetti Vincent RChief Operating OfficerSell2,500.0019.5748,921.2562,996.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm
2020-07-17Anicetti Vincent RChief Operating OfficerBuy12,500.0012.70158,750.0063,556.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm
2019-10-18Jean-Frederic ViretChief Financial OfficerSell1,388.0019.0226,399.766,385.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319025822/0000899243-19-025822-index.htm
2019-11-20Jean-Frederic ViretChief Financial OfficerBuy3,159.0010.0531,747.956,462.00https://www.sec.gov/Archives/edgar/data/1512762/000156761919022077/0001567619-19-022077-index.htm
2020-01-17Anicetti Vincent RChief Operating OfficerBuy2,500.002.506,251.2565,496.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm
2020-01-12JAMES HEALYDirectorBuy20,000.0012.37247,400.0070,086.00https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm
2019-09-23Jean-Frederic ViretChief Financial OfficerSell740.0021.7816,117.207,773.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319024242/0000899243-19-024242-index.htm
2019-10-16Jean-Frederic ViretChief Financial OfficerSell3,159.0019.0060,021.007,773.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319025758/0000899243-19-025758-index.htm
2019-08-19Jean-Frederic ViretChief Financial OfficerSell3,000.0019.0457,120.008,513.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319022200/0000899243-19-022200-index.htm
2019-08-21Jean-Frederic ViretChief Financial OfficerSell6,058.0021.75131,765.748,513.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm
2019-09-18Jean-Frederic ViretChief Financial OfficerSell3,159.0020.4464,559.858,513.00https://www.sec.gov/Archives/edgar/data/1512762/000089924319023989/0000899243-19-023989-index.htm